US Manufacturing Report
Posts
This Week in Manufacturing - 2/4/26

This Week in Manufacturing - 2/4/26

A reshoring booster from the pharma industry

February 04, 2026

Love staying up to date? Forward this to a friend to subscribe!

This report is brought to you in partnership with Sustainment, a market network dedicated to the success of American Manufacturing. Learn More →

💴 This Week in Manufacturing

This week’s manufacturing news points to a shift from rhetoric to execution. Regulatory changes in pharmaceuticals, major private investment, and renewed focus on critical inputs all signal that reshoring is moving from intent to action. The emphasis is no longer just on megaprojects, but on rebuilding the upstream capabilities and networks where small manufacturers play a decisive role.

This week’s headlines dive deeper into changes across manufacturing from pharma to farm equipment, along with optimism for post-holiday improvement within the short days of February.

Our first podcast, from The Manufacturing Executive, breaks down six tested steps for rescuing a struggling manufacturing business. The second podcast, from Manufacturing Happy Hour, covers the other side of businesses: scaling their growth in good times.

The Social Video and Fun Fact highlight big players and big money in the US pharmaceutical industry.

Thanks for joining us!

⚙ Manufacturing Headlines

Post-holiday reordering boosts US manufacturing in January [Reuters]
FDA has new scheme to boost US manufacturing [Pharmaceutical Technology]
Corning, Meta ink $6B deal supporting US manufacturing [Construction Dive]
John Deere’s $20 Billion U.S. Manufacturing Pivot [Yahoo! Finance]
Honda, GM to End U.S. Manufacturing Joint Venture This Year [IEN]

COMMENTARY

♨️ From Intent to Execution: Signs of Momentum in America’s Industrial Base

From Policy to Production: What Small Manufacturers Are Navigating Now

If there’s a common thread running through this week’s manufacturing headlines, it’s that the conversation has shifted from why the U.S. should rebuild industrial capacity to how we actually get it done.

This week’s headlines show U.S. manufacturing moving from strategy documents to real-world execution. From regulatory reforms aimed at speeding domestic pharmaceutical production to new investments in rare earths and advanced manufacturing, the focus is shifting toward capacity that actually functions under pressure.

Just as important, the competitive lens has sharpened: America’s advantage lies not in scale alone, but in a distributed network of small manufacturers whose ability to connect, qualify, and collaborate will determine whether reshoring succeeds.

Upshot: The hardest parts of reshoring aren’t glamorous, but they’re foundational. This is where America’s long tail of small manufacturers plays an outsized role.